# GlaxoSmithKline Vaccines S.r.l. – FDA Inspection, Jun 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/c8ccef32-95e1-48e2-9a17-8596412e1bbb
Source feed: FDA_Inspections

> FDA inspection 1092010 of GlaxoSmithKline Vaccines S.r.l., June 06, 2019. 3 citations under 21 CFR parts 211 and 610. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092010
- Company Name: GlaxoSmithKline Vaccines S.r.l.
- Inspection Date: 2019-06-06
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- FDA Inspection 1233226 - 2024-01-26
- [FDA Inspection 1030020 - 2017-05-29](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/a22d58f4-696a-4e53-88fb-f0c6c3c6ed78)
- FDA Inspection 683109 - 2010-06-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)
- Issuing Officer

Company: https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/cddb07b7-c8a6-4dbd-a92c-c6ebeeb7e009

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8